About MacroSpire
Multi-domain intelligence platform combining AI with expert analysis
MacroSpire is an AI-powered intelligence platform that delivers professional-grade analysis across multiple domains, created by someone with a unique combination of technical expertise, financial industry experience, and research capabilities.
Background & Expertise
- 🎓PhD in Mathematics with 30+ years of software development experience
- 🏦Currently in a leadership position at a major UK bank
- 📈Deep interest in financial markets, monetary policy, and technology economics since the 2008 financial crisis
- 🔬Expert in academic research analysis spanning technology, science, and emerging fields
- 🏥Comprehensive medical intelligence analysis using FDA regulatory data, CDC surveillance systems, and dental health data
- 🤖Specialist in applying cutting-edge AI technology across finance, research, and medical domains
Why This Platform Exists
High-quality analysis across finance, research, and medical domains is often fragmented or behind paywalls. MacroSpire integrates real-time data from Federal Reserve systems, academic research databases, FDA/CDC health surveillance, dental health data, and global markets. By combining these diverse data sources with advanced AI, we deliver institutional-quality intelligence accessible to all — whether you need economic analysis, research insights, or medical intelligence.
Technical Innovation
Built using Spring AI with real-time integration to diverse data sources — Federal Reserve economic data, academic research papers (arXiv, Semantic Scholar), FDA regulatory systems, CDC surveillance networks, and medical databases, and global market feeds. MacroSpire demonstrates how AI can enhance rather than replace human expertise across multiple domains. The system combines automated content generation with human editorial oversight to ensure quality and relevance whether analyzing monetary policy, scientific breakthroughs, or medical intelligence.
🤖 AI-Assisted Content with Human Editorial Review
This platform combines AI-powered analysis with comprehensive human editorial oversight.While artificial intelligence generates initial drafts using real-time data from the Federal Reserve (FRED), FOMC statements, and U.S. Treasury sources, all published content undergoes human review and editing.
Our editorial process includes development-phase generation, human fact-checking and editing via our Content Management Database (CMDB), and production publishing only after editorial approval. This ensures content accuracy and relevance while leveraging AI's analytical capabilities.
Content is provided for informational purposes and should not be considered professional financial advice. Always consult qualified financial professionals before making investment decisions.
Data Sources & Methodology
Our multi-domain analysis draws from authoritative sources across three key areas:
📈 Financial & Economic
- • Federal Reserve Economic Data (FRED)
- • Federal Open Market Committee (FOMC) statements
- • U.S. Treasury yield and economic data
- • Yahoo Finance market data
- • Financial news (Reuters, CNBC, BBC Business)
🔬 Academic Research
- • arXiv preprint repository
- • Semantic Scholar academic database
- • NASA research and space data
- • Scientific journals and publications
🏥 Medical Intelligence
- • FDA drug approvals and medical device data
- • CDC public health surveillance (NORS, PLACES)
- • Health regulatory enforcement and adverse events
- • CDC oral health surveillance (NOHSS Adult Indicators)
- • FDA dental device approvals and medication data
- • CDC water fluoridation and dental access measures
Questions or feedback? MacroSpire represents ongoing innovation in AI-powered multi-domain intelligence.